Bristol-Myers Squibb Co (LTS:0R1F)
$ 54.48 -1.095 (-1.97%) Market Cap: 109.81 Bil Enterprise Value: 153.11 Bil PE Ratio: 0 PB Ratio: 6.41 GF Score: 84/100

Bristol-Myers Squibb Co at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 09, 2021 / 08:00PM GMT
Release Date Price: $60.93 (+0.13%)
Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Okay. Good afternoon. My name is Carter Gould. I am a senior analyst here at Barclays. Good afternoon, and welcome to our fireside chat with Bristol-Myers Squibb. Representing the company is CFO, David Elkins, who is joining us by phone.

David, thank you very much for joining us today, and looking forward to the conversation.

David V. Elkins
Bristol-Myers Squibb Company - Executive VP & CFO

As am I, Carter. Thanks for having me.

Questions & Answers

Carter Lewis Gould
Barclays Bank PLC, Research Division - Senior Analyst

Great. David, so we're just going to jump right in. I guess the question we get asked the most often is just around Bristol's ability to really sort of manage margins over the midterm with, yes, a number of launches, but also, some LOEs starting to hit. So I guess, if you could just kind of help us think through that period, what gives you confidence in some of the push/pulls, say, between now and,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot